Clinical Trial Update: Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating gefitinib (ZD1839) in combination with irinotecan and vincristine in pediatric patients with refractory solid tumors; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Camptosar (irinotecan)
• Iressa (gefitinib)
• Oncovin (vincristine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED